|
| 37732473 | Ascertainment and Statistical Issues for Randomized Trials of Cardiovascular Interventions for Cognitive Impairment and Dementia. | Hypertension | 2024 |
| 37932961 | Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease. | Alzheimers Dement | 2024 |
| 36086926 | Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37458272 | Trial of Solanezumab in Preclinical Alzheimer's Disease. | N Engl J Med | 2023 |
| 37091309 | Safety and tolerability of lumbar puncture for the evaluation of Alzheimer's disease. | Alzheimers Dement (Amst) | 2023 |
| 36710683 | Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease. | J Alzheimers Dis | 2023 |
| 36798314 | Heterogeneity in Preclinical Alzheimer's Disease Trial Cohort Identified by Image-based Data-Driven Disease Progression Modelling. | medRxiv | 2023 |
| 36627206 | Natural cubic splines for the analysis of Alzheimer's clinical trials. | Pharm Stat | 2023 |
| 35971310 | The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease. | Alzheimers Dement | 2023 |
| 36372959 | Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under-represented populations. | Alzheimers Dement | 2023 |
| 35962782 | Tau positron emission tomography in preclinical Alzheimer's disease. | Brain | 2023 |
| 35213778 | Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI). | Alzheimers Dement | 2022 |
| 35542998 | Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial. | J Prev Alzheimers Dis | 2022 |
| 35929983 | Preoperative Ultrasound-guided Percutaneous Cryoneurolysis for the Treatment of Pain after Mastectomy: A Randomized, Participant- and Observer-masked, Sham-controlled Study. | Anesthesiology | 2022 |
| 36281665 | Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid. | J Prev Alzheimers Dis | 2022 |
| 35226724 | Basal Infusion versus Automated Boluses and a Delayed Start Timer for "Continuous" Sciatic Nerve Blocks after Ambulatory Foot and Ankle Surgery: A Randomized Clinical Trial. | Anesthesiology | 2022 |
| 33359337 | Time between milestone events in the Alzheimer's disease amyloid cascade. | Neuroimage | 2021 |
| 33778148 | Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial-Ready Cohort study. | Alzheimers Dement (N Y) | 2021 |
| 34430703 | Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. | Alzheimers Dement (Amst) | 2021 |
| 34158376 | Serratus anterior plane versus paravertebral nerve blocks for postoperative analgesia after non-mastectomy breast surgery: a randomized controlled non-inferiority trial. | Reg Anesth Pain Med | 2021 |
| 34101781 | Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data. | J Prev Alzheimers Dis | 2021 |
| 32220881 | Response to: 'erector spinae plane and paravertebral blocks have similar opioid-sparing effects following breast surgery. | Reg Anesth Pain Med | 2020 |
| 31969443 | Erector spinae plane versus paravertebral nerve blocks for postoperative analgesia after breast surgery: a randomized clinical trial. | Reg Anesth Pain Med | 2020 |
| 33163609 | Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study. | Alzheimers Dement (Amst) | 2020 |
| 32920624 | TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology. | J Prev Alzheimers Dis | 2020 |
| 32920622 | Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials. | J Prev Alzheimers Dis | 2020 |
| 32920621 | The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview. | J Prev Alzheimers Dis | 2020 |
| 32777010 | Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. | JAMA Neurol | 2020 |
| 32250387 | Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals. | JAMA Neurol | 2020 |
| 32211510 | Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease. | Alzheimers Dement (N Y) | 2020 |
| 32270600 | Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach. | Alzheimers Dement | 2020 |
| 32140682 | Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention. | Brain Commun | 2020 |
| 32568367 | Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. | JAMA Neurol | 2020 |
| 32315118 | The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults. | Ann Clin Transl Neurol | 2020 |
| 29168432 | Bayesian latent time joint mixed effect models for multicohort longitudinal data. | Stat Methods Med Res | 2019 |
| 31329216 | Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial. | JAMA Neurol | 2019 |
| 31254120 | Predicting the course of Alzheimer's progression. | Brain Inform | 2019 |
| 31367671 | The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease. | Alzheimers Dement (N Y) | 2019 |
| 31156181 | Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). | J Alzheimers Dis | 2019 |
| 31094804 | Continuous Popliteal-Sciatic Blocks for Postoperative Analgesia: Traditional Proximal Catheter Insertion Superficial to the Paraneural Sheath Versus a New Distal Insertion Site Deep to the Paraneural Sheath. | Anesth Analg | 2019 |
| 30872114 | A randomized clinical trial to evaluate home-based assessment of people over 75Â years old. | Alzheimers Dement | 2019 |
| 30458305 | Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers. | Neuroimage | 2019 |
| 30639421 | Predicting diagnosis and cognition with <sup>18</sup>F-AV-1451 tau PET and structural MRI in Alzheimer's disease. | Alzheimers Dement | 2019 |
| 29750695 | Proximal Versus Distal Continuous Adductor Canal Blocks: Does Varying Perineural Catheter Location Influence Analgesia? A Randomized, Subject-Masked, Controlled Clinical Trial. | Anesth Analg | 2018 |
| 29803541 | Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. | Alzheimers Dement | 2018 |
| 29929929 | Response to Zywieck and Kirkby paper. | Neurobiol Aging | 2018 |
| 30089306 | Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative. | Neurodegener Dis | 2018 |
| 30272103 | Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline? | J Nutr Health Aging | 2018 |
| 30297140 | Participant satisfaction with dementia prevention research: Results from Home-Based Assessment trial. | Alzheimers Dement | 2018 |
| 30456292 | Bayesian latent time joint mixed-effects model of progression in the Alzheimer's Disease Neuroimaging Initiative. | Alzheimers Dement (Amst) | 2018 |